ARCHIVE
More Drugs to Come from Bio-ventures than Drug Firms: Prof. Morishita of AnGes MG
Prof. Ryuichi Morishita of Osaka University Graduate School of Medicine, the founder of the bio-venture company AnGes MG, predicted at a symposium in Osaka on December 20 that Saito Life Science Park in north Osaka will become the largest bio-cluster…
To read the full story
ARCHIVE
- Pharmaceutical Industry Salary Survey 2011
December 26, 2011
- AFII Grants France-Japan Investment Award to sanofi-aventis, Canon
December 19, 2011
- Plan Like Your Life Depended on It… It Just Might!
December 5, 2011
- Interviewing and Hiring: Strong Character Plus Good Attitude Equals Great Potential
November 14, 2011
- A Cry from the Next Generation of Japanese Pharmaceutical Executives
October 24, 2011
Strategic Talent Acquisition in the Japanese Life Sciences Sector: Your Market Intelligence Briefing
Focus: How to Get the Talent You Need in a Tough MarketThe Japanese life sciences sector presents a challenging landscape for global companies. To succeed, you must move beyond reactive hiring and adopt a truly strategic talent acquisition model. Our…





